Skip to content

Glossary

Accretion / Dilution

A financial analysis that determines whether a proposed acquisition will increase (accretion) or decrease (dilution) the acquirer's earnings per share — a key test for public company M&A transactions.

What Is Accretion / Dilution Analysis?

Accretion/dilution analysis (often called an “accretion/dilution test” or “EPS impact analysis”) evaluates whether a proposed acquisition will increase or decrease the acquiring company’s earnings per share (EPS). If the combined company’s pro forma EPS exceeds the acquirer’s standalone EPS, the deal is accretive. If pro forma EPS falls below the standalone figure, the deal is dilutive.

This analysis is one of the most important tests in public company M&A. While a deal can be strategically sound even if initially dilutive, acquirers and their boards face significant scrutiny from shareholders and analysts when announcing dilutive transactions.

How the Analysis Works

Step-by-Step Process

  1. Calculate the acquirer’s standalone EPS — the starting baseline
  2. Determine the target’s contribution — the target’s net income that will be added to the combined company
  3. Account for transaction adjustments:
    • Foregone interest on cash used for the acquisition
    • New interest expense on acquisition-related debt
    • Additional shares issued (in stock-for-stock deals)
    • Synergies (net of integration costs)
    • Amortisation of acquired intangible assets
    • Tax effects of all adjustments
  4. Calculate pro forma combined EPS — combined net income divided by the new share count
  5. Compare — pro forma EPS vs. standalone EPS determines accretion or dilution

Simplified Example

MetricAcquirer (Standalone)Pro Forma (Combined)
Net income$100M$135M
Shares outstanding50M60M (10M new shares issued)
EPS$2.00$2.25
Impact12.5% accretive

Key Drivers of Accretion / Dilution

Purchase Price and Payment Method

  • Cash-financed deals are more likely to be accretive if the target’s earnings yield (E/P ratio) exceeds the acquirer’s after-tax borrowing cost
  • Stock-financed deals are accretive if the target’s P/E ratio is lower than the acquirer’s — the acquirer is buying cheaper earnings
  • Mixed consideration blends both effects

Synergies

Cost and revenue synergies directly improve pro forma net income and are often the factor that tips a marginally dilutive deal into accretion. However, analysts scrutinise synergy assumptions carefully.

Financing Costs

  • Interest expense on new debt reduces pro forma earnings
  • Tax deductibility of interest partially offsets this impact
  • The net effect depends on the acquirer’s marginal tax rate and the interest rate on acquisition debt

Purchase Price Accounting

Under acquisition accounting, the target’s assets are marked to fair value, creating goodwill and identifiable intangible assets. The amortisation of identifiable intangibles (customer relationships, technology, brand names) reduces pro forma earnings and can cause dilution even in operationally sound deals — a nuance that AI-powered valuation platforms can help model more precisely.

Accretive vs. Dilutive — What It Means

Accretive Deal

  • Pro forma EPS > standalone EPS
  • Generally viewed favourably by the market
  • Easier to secure board and shareholder approval
  • Does not guarantee the deal is value-creating (the acquirer may have overpaid relative to intrinsic value)

Dilutive Deal

  • Pro forma EPS < standalone EPS
  • Requires a compelling strategic rationale to justify
  • Management must articulate a clear path to future accretion (synergies, growth)
  • Common in transformative or strategic acquisitions — often part of a broader corporate development strategy — where near-term dilution is accepted for long-term value creation

Limitations of Accretion / Dilution Analysis

  • EPS is an accounting metric — accretion does not necessarily mean value creation, and dilution does not necessarily mean value destruction (Corporate Finance Institute)
  • Short-term focus — the analysis typically considers year-one or year-two EPS impact, potentially overlooking long-term strategic benefits
  • Easily manipulated — aggressive synergy assumptions, favourable financing assumptions, or excluding certain costs can make any deal appear accretive
  • Ignores risk — the analysis does not account for execution risk, integration risk, or the probability of achieving projected synergies

Accretion / Dilution in Asia Pacific

Accretion/dilution analysis is most relevant for public company acquisitions, which represent a significant portion of M&A activity in markets like Australia (ASX), Japan (TSE), Hong Kong (HKEX), and India (BSE/NSE). Cross-border acquirers must account for differences in accounting standards (IFRS vs. local GAAP), varying tax rates, and currency effects when performing the analysis. AI-native platforms like Amafi help advisors model the financial impact of proposed transactions across the region’s diverse accounting and regulatory environments.

Related Terms